Impact Biomedical IBO - Options Chain | ADVFN

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
AMEX
Impact Biomedical Inc (IBO)
Impact Biomedical Inc (IBO) Options

Impact Biomedical Inc (IBO)

2.08

-0.07

(-3.26%)

Closed February 16 4:00PM

Delayed by 15 minutes

2.08

0.00

(0.00%)

After Hours: 4:00PM

Delayed by 15 minutes

IBO Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
15.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
20.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
15.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
20.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
JTAIJet AI Inc	$ 6.02 (133.33%)	101.64M
SRMSRM Entertainment Inc	$ 0.6999 (95.50%)	248.48M
WRDWeRide Inc	$ 31.4877 (83.39%)	20.57M
INLFINLIF Limited	$ 16.27 (80.58%)	7.67M
MBRXMoleculin Biotech Inc	$ 2.1201 (66.94%)	134.88M
BLACBellevue Life Sciences Acquisition Corporation	$ 3.08 (-56.31%)	430.77k
BLACUBellevue Life Sciences Acquisition Corporation	$ 3.36 (-52.68%)	5.21k
CSAICloudastructure Inc	$ 19.0001 (-49.58%)	1.03M
NEXNNexxen International Ltd	$ 10.30 (-49.16%)	164.82k
BSLKBolt Projects Holdings Inc	$ 0.6626 (-46.13%)	13.4M
CNSPCNS Pharmaceuticals Inc	$ 0.1415 (31.26%)	480.49M
MGOLMGO Global Inc	$ 0.7176 (-15.08%)	411.17M
SRMSRM Entertainment Inc	$ 0.6999 (95.50%)	248.48M
INTCIntel Corporation	$ 23.60 (-2.20%)	225.04M
NVDANVIDIA Corporation	$ 138.85 (2.63%)	189.56M

Disquisition

Disquisition 4 months ago

INCREDIBLE DUMPING

TrendTrade2016

TrendTrade2016 5 months ago

IBO...BOTTOM BOUNCER

rizah

rizah 2 years ago

All resolutions were approved by the required majority of shareholders at Universal Ibogaine Inc.'s (IBO)annual general meeting ("AGM"), which was held on October 3, 2022 in Vancouver, British Columbia. The company is a life sciences company with a mission to provide medicalized ibogaine-centered addiction care.

harry_brat

harry_brat 3 years ago

$IBO held on to its renowned capital market advisor

UI recently announced that it has retained Mr. Shayne Nyquvest as their capital market advisor in a consulting role. Mr. Nyquvest has substantial capital markets experience, having assisted companies in the mining, cannabis, and other growing industries with strategic fund-raising initiatives for over 4 decades.

Blue_Digital_Media

Blue_Digital_Media 3 years ago

Universal Ibogaine Inc. thanks to David for his contributions to the Company during his tenure as a Director.

Watch now IBO for latest stock information.

Impact Biomedical

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions